Icon offers $52m for CCH’s clinical services division, plus updates from PPD, Aptuit, Argenta, Quintiles and Verum.de.
Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

